ACVR1 Chromosome 2

Activin A receptor type 1
16 variants 16 Health Risk

Upload your DNA to see your personal genotypes for variants in ACVR1.

What This Gene Does
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
Type 1 receptor serine/threonine kinases
Locus Type
gene with protein product
Location
2q24.1
Ensembl
ENSG00000115170
Associated Conditions (10)
Inborn genetic diseases
Progressive myositis ossificans
Epicanthus
ACVR1-related disorder
Ependymoma
Diffuse pediatric-type high-grade glioma
H3-wildtype and IDH-wildtype
Diffuse midline glioma
H3 K27M-mutant
Neoplasm
Key Variants
All Variants (16)
RSID Category Clinical Significance Conditions
RS201872272 Health Risk Conflicting classifications of pathogenicity Inborn genetic diseases, Inborn genetic diseases
RS371512479 Health Risk Conflicting classifications of pathogenicity Progressive myositis ossificans, Progressive myositis ossificans
RS373855918 Health Risk Conflicting classifications of pathogenicity
RS748424210 Health Risk Conflicting classifications of pathogenicity Progressive myositis ossificans, Progressive myositis ossificans
RS750457181 Health Risk Conflicting classifications of pathogenicity Inborn genetic diseases, Inborn genetic diseases
RS914942419 Health Risk Conflicting classifications of pathogenicity
RS983884500 Health Risk Conflicting classifications of pathogenicity
RS863224846 Health Risk Likely pathogenic Progressive myositis ossificans, Progressive myositis ossificans
RS121912678 Health Risk Pathogenic Progressive myositis ossificans, Inborn genetic diseases, Epicanthus
RS121912679 Health Risk Pathogenic Progressive myositis ossificans, Diffuse midline glioma, H3 K27M-mutant
RS121912680 Health Risk Pathogenic Progressive myositis ossificans, Progressive myositis ossificans
RS387906588 Health Risk Pathogenic Progressive myositis ossificans, Neoplasm, Progressive myositis ossificans
RS387906590 Health Risk Pathogenic Progressive myositis ossificans, Progressive myositis ossificans
RS387906591 Health Risk Pathogenic Progressive myositis ossificans, Progressive myositis ossificans
RS797045135 Health Risk Pathogenic Progressive myositis ossificans, Progressive myositis ossificans
RS387906589 Health Risk Pathogenic/Likely pathogenic Progressive myositis ossificans, Inborn genetic diseases, Ependymoma
Sign Up to Analyze Your DNA Log In